Holderness Investments Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.39M Sell
13,881
-37
-0.3% -$8.62K 0.68% 32
2025
Q4
$2.88M Buy
13,918
+6
+0% +$1.19K 0.59% 44
2025
Q3
$2.58M Sell
13,912
-1,668
-11% -$286K 0.53% 49
2025
Q2
$2.38M Sell
15,580
-3,247
-17% -$499K 0.51% 51
2025
Q1
$3.12M Buy
18,827
+16
+0.1% +$2.5K 0.73% 37
2024
Q4
$2.72M Sell
18,811
-59
-0.3% -$9.14K 0.6% 40
2024
Q3
$3.06M Hold
18,870
0.67% 36
2024
Q2
$2.76M Sell
18,870
-87
-0.5% -$12.9K 0.65% 37
2024
Q1
$3M Sell
18,957
-409
-2% -$65.1K 0.73% 34
2023
Q4
$3.04M Sell
19,366
-116
-0.6% -$17.8K 0.83% 32
2023
Q3
$3.03M Sell
19,482
-285
-1% -$47K 1.18% 19
2023
Q2
$3.27M Sell
19,767
-2,269
-10% -$366K 1.21% 19
2023
Q1
$3.42M Sell
22,036
-158
-0.7% -$25.5K 1.37% 18
2022
Q4
$3.92M Buy
22,194
+108
+0.5% +$18.6K 1.69% 11
2022
Q3
$3.61M Sell
22,086
-1,129
-5% -$191K 1.64% 12
2022
Q2
$4.12M Sell
23,215
-1,445
-6% -$257K 1.72% 12
2022
Q1
$4.37M Buy
24,660
+2,077
+9% +$353K 1.46% 13
2021
Q4
$3.86M Buy
22,583
+524
+2% +$85.8K 1.14% 18
2021
Q3
$3.56M Sell
22,059
-3,259
-13% -$556K 1.18% 18
2021
Q2
$4.17M Buy
25,318
+137
+0.5% +$22.7K 1.38% 15
2021
Q1
$4.14M Buy
25,181
+2,798
+13% +$453K 1.49% 14
2020
Q4
$3.52M Sell
22,383
-1,035
-4% -$153K 1.37% 16
2020
Q3
$3.49M Buy
23,418
+579
+3% +$85.7K 1.44% 15
2020
Q2
$3.21M Buy
22,839
+2,279
+11% +$332K 1.43% 15
2020
Q1
$2.7M Buy
20,560
+606
+3% +$86K 1.52% 14
2019
Q4
$2.91M Buy
19,954
+53
+0.3% +$7.19K 1.25% 19
2019
Q3
$2.58M Sell
19,901
-7,335
-27% -$966K 1.2% 20
2019
Q2
$3.79M Buy
27,236
+559
+2% +$77.4K 1.72% 11
2019
Q1
$3.73M Sell
26,677
-643
-2% -$86.1K 1.79% 12
2018
Q4
$3.53M Buy
27,320
+318
+1% +$44.4K 1.93% 10
2018
Q3
$3.73M Buy
27,002
+386
+1% +$51.3K 1.68% 11
2018
Q2
$3.23M Buy
26,616
+88
+0.3% +$11K 1.57% 13
2018
Q1
$3.4M Sell
26,528
-646
-2% -$87.3K 1.68% 13
2017
Q4
$3.8M Sell
27,174
-304
-1% -$42.3K 1.87% 12
2017
Q3
$3.57M Buy
27,478
+157
+0.6% +$20.8K 1.86% 11
2017
Q2
$3.61M Buy
27,321
+1,950
+8% +$249K 1.92% 10
2017
Q1
$3.16M Buy
25,371
+10,436
+70% +$1.25M 1.6% 13
2016
Q4
$1.72M Buy
14,935
+175
+1% +$20.2K 1.52% 22
2016
Q3
$1.74M Sell
14,760
-215
-1% -$26.1K 1.74% 14
2016
Q2
$1.82M Sell
14,975
-175
-1% -$19.9K 1.83% 15
2016
Q1
$1.64M Buy
15,150
+208
+1% +$21.5K 1.56% 23
2015
Q4
$1.53M Buy
14,942
+302
+2% +$30.4K 1.52% 25
2015
Q3
$1.37M Buy
14,640
+334
+2% +$32.3K 1.44% 24
2015
Q2
$1.39M Buy
14,306
+4
+0% +$401 1.42% 24
2015
Q1
$1.44M Hold
14,302
1.46% 23
2014
Q4
$1.5M Buy
+14,302
New +$1.51M 1.53% 18

Other funds holding JNJ

Holderness Investments Company's JNJ Position: Q1 2026 in Review

Holderness Investments Company reduced its Johnson & Johnson (JNJ) stake by 0.27% in Q1 2026, selling an estimated $8.62K and leaving 13,881 shares worth $3.39M. The position accounts for 0.68% of the portfolio, ranked #32.

Holderness Investments Company first reported a position in JNJ in Q4 2014 and has held it in 46 quarters since. The position peaked at $4.37M in Q1 2022. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Holderness Investments Company held 13,881 shares of Johnson & Johnson worth $3.39M as of Q1 2026.
  • Holderness Investments Company sold 37 Johnson & Johnson shares in Q1 2026, an estimated $8.62K.
  • Johnson & Johnson made up 0.68% of Holderness Investments Company's portfolio in Q1 2026, its #32 holding.
  • Holderness Investments Company first reported a position in Johnson & Johnson in Q4 2014 and has held it in 46 quarters since.
  • Holderness Investments Company's Johnson & Johnson position peaked at $4.37M in Q1 2022.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Holderness Investments Company's 13F filing for Q1 2026, filed 12 May 2026.